佰金生命科学：延迟刊发2025年度业绩及暂停买卖 金十数据6月25日讯，佰金生命科学(01466.HK)公告，由于附属公司管理层变更后的交接过程较预期耗 时更长，且公司于本周初方全面控制附属公司的运营，故截至2025年3月31日止年度之年度业绩将延迟 刊发。核数师及公司需要更多时间以编制2025年度业绩。预计2025年度业绩将于2025年7月25日前刊 发。根据上市规则第13.5条，若发行人未能根据上市规则之规定刊发定期财务资料，联交所通常会要求 暂停买卖发行人之证券，而暂停买卖通常会持续至发行人刊发载有必要财务资料之公告为止。倘公司未 能于2025年6月30日或之前向股东公布2025年度业绩，预期公司股份将于2025年7月2日上午9时正起于联 交所暂停买卖，以待刊发2025年度业绩公告。 ...

Financial Performance - For the six months ended September 30, 2024, the company reported a profit before income tax of HK$706,000[19] - The Company reported a total comprehensive loss of HK$9,682 for the period, compared to a loss of HK$6,227 in the previous period, indicating an increase in losses of approximately 55.5%[41] - Revenue for the six months ended September 30, 2024, was HK$70,900,000, a significant increase from HK$25,121,000 in the same period of 2023, representing a growth of 182%[126] - Gross profit for the period was HK$16,805,000, compared to HK$3,617,000 in the previous year, indicating a substantial improvement[126] - The operating profit for the period was HK$794,000, a recovery from an operating loss in the previous year[126] - Loss for the period decreased to HK$1,901,000 from HK$2,318,000 year-over-year, showing a reduction in losses[127] - Total comprehensive expense for the period was HK$5,356,000, compared to HK$3,079,000 in the prior year, reflecting increased expenses[127] Assets and Liabilities - Total assets as of September 30, 2024, amounted to HK$147,717,000, an increase from HK$121,320,000 as of March 2024[15] - Current liabilities were reported at HK$73,885,000, with trade and other payables amounting to HK$53,159,000[15] - Total liabilities stood at HK$129,259,000, with unallocated corporate liabilities at HK$59,379,000[90] - As of September 30, 2024, total assets amounted to HK$196,802, with unallocated goodwill at HK$48,363 and unallocated corporate assets at HK$25,520[55] - The total liabilities of the Company as of September 30, 2024, were HK$84,010, with unallocated corporate liabilities at HK$53,443[55] - Non-current liabilities increased significantly to HK$55,374,000 as of September 30, 2024, up from HK$43,016,000 as of March 31, 2024[129] - Net assets decreased to HK$107,436,000 from HK$112,792,000, indicating a decline in overall asset value[129] Cash Flow - The company experienced a net cash used in operating activities of HK$8,392,000 for the six months ended September 30, 2024[19] - The group reported a net cash generated from investing activities of HK$230,000, a decrease from HK$690,000 in the previous year[112] - Net cash generated from financing activities increased significantly to HK$18,000,000 compared to HK$371,000 in the prior period[112] - Cash and cash equivalents stood at HK$44,370,000 as of September 30, 2024[15] - Cash and cash equivalents at the end of the period were HK$44,370,000, up from HK$41,231,000 year-over-year[112] Segment Performance - Segment revenue from pearl and fine jewellery products was HK$70,151, while skincare business revenue was HK$3,598, and research and solutions development services generated HK$16,114, contributing to a total segment revenue of HK$122,919[55] - The skincare solutions business segment generated a profit of HK$7,204,000, while the sales of pearls and fine jewellery products reported a loss of HK$2,078,000[86] - The total segment profit for the group was HK$5,088,000, indicating a positive performance overall despite some segments reporting losses[86] - The skincare solutions segment's revenue was HK$15,156,000, while research and solutions development services reported revenue of HK$849,000[86] - The strategic investment and financial services segment did not report any revenue during this period[86] - Segment revenue for the six months ended September 30, 2024, totaled HK$70,900,000, with the sales of pearls and fine jewellery products contributing HK$50,417,000[86] Corporate Governance and Compliance - The interim financial statements have been prepared in accordance with Hong Kong Accounting Standards, ensuring compliance with local regulations[24] - The Company has complied with all code provisions as set out in the Corporate Governance Code throughout the six months ended 30 September 2024, except for the separation of the roles of chairman and chief executive officer[144] - The Company has adopted a corporate governance statement of policy to guide the application of corporate governance principles[144] - The condensed consolidated financial statements have not been audited but have been reviewed by the Company's audit committee[59] - The Audit Committee comprises three independent non-executive Directors who have recommended the adoption of the interim results to the Board[199] Shareholder and Equity Information - For the six months ended September 30, 2024, the total equity attributable to equity holders of the Company decreased to HK$86,626, down from HK$96,308 as of April 1, 2024, representing a decline of approximately 10.5%[41] - The Company has no controlling shareholder, with Pacific Wish Limited being the substantial shareholder[45] - The Company was listed on the Main Board of The Stock Exchange of Hong Kong Limited on October 17, 2014[45] - The Group's share capital as of 30 September 2024 was HK$200,000, with 10,000,000 ordinary shares authorized at HK$0.02 each[183] - The Company issued 39,954,338 new shares at an issue price of HK$0.2628 to satisfy the aggregate consideration for the acquisition of Tonnett Group[165] Strategic Focus and Development - The company is focused on expanding its skincare solutions through self-developed brands and high-end functional skincare products[23] - The company is engaged in strategic investments and financial services, enhancing its operational capabilities[23] - The company is focused on expanding its strategic investment and financial services segment, aiming for growth in this area[114] - The company is actively pursuing new product development and market expansion strategies to enhance its competitive position[114] - The group currently operates five segments following the acquisition of Tonnett Julis Holdings Limited on February 9, 2024[81] Other Financial Information - The Company has adopted new and amended HKFRSs effective from April 1, 2024, but these changes had no material impact on the financial performance for the current and prior periods[51] - The financial statements have been prepared on a historical cost basis, except for certain financial instruments measured at fair values[47] - Interest received decreased to HK$609,000 from HK$690,000 in the previous year, indicating a potential area for improvement[112] - Interest expenses on borrowings increased to HK$289,000 in the six months ended 30 September 2024, compared to HK$87,000 in the same period in 2023[167] - Key management compensation for the six months ended 30 September 2024 was HK$2,374,000, a decrease from HK$5,946,000 in the same period in 2023[168] - The Group incurred rental expenses of HK$180,000 for the office property rented from a related party during the six months ended 30 September 2024, consistent with the previous year[171] - The landlord of the rented property is a wholly owned subsidiary of Far East Holdings International Limited, which is listed on the Main Board of the Stock Exchange[172] - The Group's related party transactions were conducted based on mutually agreed terms[171] - There were no purchases, sales, or redemptions of the Company's listed securities for the six months ended 30 September 2024[198] - The Group's segment performance monitoring allocates all liabilities to operating segments, excluding certain financial instruments and borrowings[187] - The changes in director's information were disclosed in accordance with Rule 13.51B(1) of the Listing Rules, with no other information required to be disclosed[197] - The group has not completed the initial allocation of goodwill from a business combination, which will be finalized in the current financial year[91] - No options were lapsed, granted, exercised, or cancelled under the New Share Option Scheme during the reporting period[142] - The new share option scheme will be valid for ten years and includes performance targets for options to vest[138] - The maximum number of shares that may be issued upon exercise of Options yet to be granted under the New Share Option Scheme is 67,925,226, representing approximately 10% of the total number of shares in issue of the Company (i.e. 679,252,266 ordinary shares)[142]

Financial Performance - Revenue for the six months ended September 30, 2024, was HKD 70,900,000, compared to HKD 25,121,000 for the same period in 2023, representing a 182% increase[5] - Gross profit for the same period was HKD 16,805,000, up from HKD 7,613,000, indicating a 121% increase year-over-year[5] - The net loss for the six months ended September 30, 2024, was HKD 1,901,000, an improvement from a net loss of HKD 2,318,000 in the prior year[5] - The company reported a significant increase in other income, netting HKD 3,617,000 compared to HKD 605,000 in the previous year, marking a 498% increase[5] - For the six months ended September 30, 2024, total revenue was HKD 70,900 million, with sales of pearl and high-end jewelry products contributing HKD 50,417 million[24] - The segment profit for the pearl and high-end jewelry products was a loss of HKD 2,078 million, while the skincare solutions business generated a profit of HKD 7,204 million[24] - The company reported a consolidated loss attributable to shareholders of approximately HKD 6,200,000 for the six months ended September 30, 2024, compared to a loss of HKD 2,300,000 for the same period in 2023[86] Assets and Liabilities - Total assets as of September 30, 2024, were HKD 147,717,000, compared to HKD 121,320,000 as of March 31, 2024, reflecting a 22% increase[9] - Current liabilities increased to HKD 73,885,000 from HKD 40,994,000, representing an 80% rise[9] - The company’s equity attributable to shareholders decreased to HKD 86,626,000 from HKD 96,308,000, indicating a decline of 10%[11] - Total liabilities were HKD 129,259 million, with HKD 69,880 million related to segment liabilities[27] - The total accounts receivable, net of expected credit loss provisions, amounted to HKD 26,392,000 as of September 30, 2024[57] Cash Flow and Financial Position - The company’s cash and cash equivalents stood at HKD 44,370,000 as of September 30, 2024, compared to HKD 37,884,000 at the end of March 2024, showing a 17% increase[9] - The group’s total equity was approximately HKD 107,400,000 as of September 30, 2024, down from HKD 112,800,000 as of March 31, 2024, due to losses incurred during the period[115] - The current ratio as of September 30, 2024, was 2.0, down from 3.0 as of March 31, 2024, indicating a decrease in liquidity[115] Business Operations and Strategy - The company operates primarily in the procurement, processing, design, production, and wholesale distribution of pearl and high-end jewelry products[14] - The company plans to relocate its main business office to a new address effective October 30, 2024[13] - The company has reported a significant increase in sales and operational efficiency, which is expected to continue into the next fiscal period[5] - The company aims to enhance its market presence through new product development and potential mergers and acquisitions[27] - The company is actively collaborating with a local brand to expand into the high-end jewelry market in Hong Kong[88] - The company has begun exploring the high-end jewelry market using high-quality materials and craftsmanship, with a local brand partnership contributing 21.4% to total revenue as of September 30, 2024[127] Acquisitions and New Segments - The company completed the acquisition of Tonnett Julis Holdings Limited and its subsidiaries on February 9, 2024, expanding its operational segments to five[22] - The skincare solutions business segment operates under the brand "FO," selling products through contracts with cosmetic stores and hospitals, as well as online platforms[22] - Revenue contribution from the newly acquired skincare solutions business segment was HKD 20,500,000 in the first half of 2024, with HKD 15,200,000 from skincare solutions, HKD 800,000 from R&D services, and HKD 4,500,000 from brand marketing and consulting services[94] - The company has agreed to acquire a target group primarily engaged in scientific and pharmaceutical research services for a total consideration of HKD 42,000,000[99] Employee and Operational Costs - The company’s employee benefits expenses, including directors' remuneration, were HKD 9,368,000 for the six months ended September 30, 2024, compared to HKD 8,620,000 in 2023, an increase of 9%[42] - The group employed a total of 84 employees as of September 30, 2024, with total employee costs amounting to approximately HKD 9,400,000, compared to HKD 8,600,000 in the first half of 2023[122] - Selling and administrative expenses increased by approximately HKD 7,700,000 or 65.3% to about HKD 19,500,000, primarily due to expenses from newly acquired businesses[112] Market Outlook and Future Plans - The company anticipates that the global jewelry market will recover to normal levels in the foreseeable future despite current fluctuations[87] - The skincare market is considered to have significant potential, with the group's pearl products being integrated as ingredients in skincare products, creating opportunities for collaboration and cross-selling[131] - The group will continue to strengthen its pearl and high-end jewelry business by participating in major jewelry exhibitions to optimize business efficiency and productivity[128]

Financial Performance - Total revenue for the fiscal year ending March 31, 2024, was HKD 53,676,000, a decrease from HKD 86,880,000 in the previous year, representing a decline of approximately 38.3%[4] - Gross profit for the fiscal year was HKD 18,100,000, compared to HKD 7,827,000 in the previous year, indicating an increase of approximately 131.1%[4] - The net loss attributable to the company for the year was HKD 8,545,000, compared to a profit of HKD 8,676,000 in the previous year, reflecting a significant shift in performance[4] - Basic and diluted loss per share for the year was HKD 0.01, compared to a profit of HKD 0.01 per share in the previous year[4] - Operating expenses increased to HKD 27,349,000 from HKD 16,254,000, marking an increase of approximately 68.5%[4] - The company reported a comprehensive loss of HKD 10,645,000 for the year ending March 31, 2024, compared to a comprehensive income of HKD 9,649,000 in 2023, indicating a significant decline in performance[5] - The company reported a loss of HKD 7,448,000 for the year ending March 31, 2024, compared to a profit of HKD 8,676,000 in 2023, indicating a significant decline in performance[65] Assets and Liabilities - The total assets as of March 31, 2024, amounted to HKD 155,808,000, an increase from HKD 78,775,000 in the previous year, reflecting growth in the company's asset base[7] - The company's cash and cash equivalents decreased to HKD 37,884,000 from HKD 41,261,000 year-over-year, showing a decline in liquidity[7] - The total liabilities increased to HKD 40,994,000 in 2024 from HKD 21,076,000 in 2023, indicating a rise in the company's financial obligations[8] - The company's equity attributable to shareholders rose to HKD 96,308,000 in 2024, up from HKD 78,288,000 in 2023, demonstrating an improvement in shareholder value[8] Strategic Initiatives - The company plans to focus on new product development and market expansion strategies in the upcoming fiscal year[3] - The company is exploring potential mergers and acquisitions to enhance its market position and operational capabilities[3] - Future guidance indicates a cautious outlook due to current market conditions and previous performance trends[3] - The company aims to improve operational efficiency and reduce costs in response to the recent financial performance[3] Acquisitions and Investments - The company completed the acquisition of Tonnett Julis Holdings Limited on February 9, 2024, which is expected to contribute to new core activities in skincare and pharmaceutical research services[14] - The company issued new shares resulting in an increase in share capital to HKD 13,585,000 from HKD 6,393,000, marking a rise of approximately 112.0%[10] - The company has recognized HKD 59,000 in interest payable on loans, an increase from HKD 37,000 in 2023[80] - The company has completed the acquisition of Tonnett Julis Holdings Limited and its group of companies for a total consideration of HKD 42,000,000, with HKD 10,500,000 paid through the issuance of shares and HKD 31,500,000 through convertible bonds[102] Revenue Breakdown - Revenue from the sale of pearls and jewelry products is HKD 50,348,000, down from HKD 85,230,000, indicating a decrease of about 41%[46] - The skincare solutions business reported a revenue of HKD 1,474,000, compared to no revenue in the previous year, marking a significant growth[46] - The brand marketing and consulting services generated revenue of HKD 1,609,000, a decrease from HKD 1,650,000, reflecting a decline of about 2.5%[46] Employee and Operational Costs - Employee benefits expenses increased to HKD 15,103,000 in 2024 from HKD 10,071,000 in 2023, reflecting a growth of approximately 50.7%[57] - Selling and administrative expenses rose by HKD 12 million or 72.3% to HKD 28.6 million, primarily due to expenses from newly acquired businesses and increased professional fees[117] Corporate Governance and Compliance - The board of directors has confirmed compliance with the corporate governance code and has not identified any issues affecting the independence of independent non-executive directors[135] - The company is committed to high standards of corporate governance to enhance transparency and protect stakeholder interests[139] Market Conditions and Future Outlook - The company plans to focus on market expansion in Asia, particularly in China, where revenue increased from HKD 538,000 in 2023 to HKD 3,328,000 in 2024[55] - The company aims to enhance its product offerings and technology development to improve future performance and market position[55] - The company plans to participate in major jewelry exhibitions worldwide to optimize operational efficiency and maintain competitiveness[111]

Financial Performance - Revenue for the six months ended September 30, 2023, was HK$25,121,000, a decrease of 49.8% compared to HK$50,002,000 in the same period of 2022[9]. - Gross profit for the same period was HK$7,613,000, down 40.4% from HK$12,763,000 year-over-year[9]. - Operating loss for the period was HK$2,906,000, compared to an operating profit of HK$11,043,000 in the previous year[9]. - Loss attributable to equity holders of the Company was HK$2,318,000, a significant decline from a profit of HK$10,258,000 in the prior year[9]. - Basic and diluted loss per share was (0.36) HK cents, compared to earnings of 1.81 HK cents per share in the same period last year[9]. - The Company reported a total comprehensive loss of HK$3,079,000 for the period, compared to a comprehensive income of HK$9,423,000 in the previous year[11]. - For the six months ended September 30, 2023, the company reported a loss of HK$3,079,000 compared to a profit of HK$9,423,000 for the same period in 2022, indicating a significant decline in performance[14]. - The company reported a loss before income tax of HK$2,318,000 for the six months ended September 30, 2023, compared to a profit of HK$10,258,000 in the prior year, highlighting a substantial downturn in profitability[16]. - The Group reported a loss attributable to equity holders of approximately HK$2,318,000 for the six months ended 30 September 2023, compared to a profit of HK$10,258,000 in 2022[81]. - The consolidated loss attributable to equity holders for the six months ended 30 September 2023 was approximately HK$2.3 million, compared to a profit of HK$10.3 million for the same period in 2022[171]. Assets and Liabilities - Total assets as of September 30, 2023, were HK$97,962,000, slightly down from HK$98,872,000 as of March 31, 2023[13]. - Net current assets decreased to HK$74,859,000 from HK$77,359,000 as of March 31, 2023[13]. - Total equity attributable to equity holders of the Company was HK$75,259,000, down from HK$78,338,000 as of March 31, 2023[13]. - The total equity attributable to equity holders of the company decreased from HK$78,062,000 as of September 30, 2022, to HK$75,259,000 as of September 30, 2023, reflecting a reduction of approximately 3.6%[14]. - Trade receivables increased to HK$21,929,000 as of September 30, 2023, compared to HK$19,744,000 as of March 31, 2023, with a net amount of HK$7,125,000 after an allowance for expected credit losses (ECL) of HK$14,804,000[91]. - Other receivables, deposits, and prepayments rose to HK$6,623,000 as of September 30, 2023, up from HK$5,984,000 as of March 31, 2023[102]. - Trade payables decreased significantly to HK$3,787,000 as of September 30, 2023, from HK$9,006,000 as of March 31, 2023[105]. - The total amount of trade and other payables and accruals was HK$19,801,000 as of September 30, 2023, compared to HK$18,755,000 as of March 31, 2023[105]. Cash Flow and Management - Cash flows from operating activities showed a net cash used of HK$376,000 for the six months ended September 30, 2023, compared to HK$10,712,000 used in the same period of 2022, indicating an improvement in cash flow management[18]. - The company generated HK$690,000 from investing activities in the first half of 2023, a significant increase from HK$4,000 in the same period of 2022[18]. - Cash and cash equivalents remained stable at HK$41,231,000, compared to HK$41,261,000 as of March 31, 2023[13]. - The cash and cash equivalents at the end of the period were HK$41,231,000, up from HK$17,289,000 at the end of September 2022, representing an increase of approximately 138.0%[18]. - The company’s finance costs decreased to HK$102,000 in the first half of 2023 from HK$789,000 in the same period of 2022, reflecting improved cost management[16]. Segment Performance - For the six months ended September 30, 2023, the segment revenue from the sale of pearls and jewellery products was HK$25,121,000[41]. - The segment profit from the sale of pearls and jewellery products was HK$137,000, while the strategic investment and financial services segment reported a loss of HK$269,000, resulting in a total segment loss of HK$132,000[41]. - Segment revenue for the sale of pearls and jewellery products was HK$48,915,000, while strategic investment and financial services generated HK$1,087,000, totaling HK$50,002,000[45]. - Segment profit for the sale of pearls and jewellery products was HK$15,241,000, with a loss of HK$1,781,000 from strategic investment and financial services, resulting in a total profit of HK$13,460,000[45]. Operational Strategy - The Group plans to launch jade products in the upcoming jewellery fair/show to boost sales and broaden the customer base, targeting mainland China and other Asian markets[178]. - The Group will continue to strictly control costs and improve operational efficiency to maintain competitiveness[179]. - The Group has been actively participating in various important jewellery and gem fairs globally to seek opportunities for customer base expansion[179]. - The management has downsized the co-working space network in Hong Kong to mitigate losses due to COVID-19 impacts[181]. - The Group's management believes the decrease in sales of pearl and jewellery products is temporary and anticipates a recovery in the global jewellery market[174]. Share Capital and Options - The company’s share capital remained unchanged at HK$12,786,000 as of September 30, 2023, consistent with the previous year[14]. - The Group completed a rights issue resulting in the issuance of 319,648,964 rights shares, raising net proceeds of approximately HK$32,772,000 for loan repayment and working capital[119]. - The share capital increased by approximately HK$6,393,000 and share premium by HK$26,379,000 following the rights issue[119]. - The maximum number of shares that may be issued upon exercise of all outstanding options under the Scheme shall not exceed 30% of the Company's issued share capital[137]. - The total number of shares issued and to be issued upon exercise of options granted to each participant in any 12-month period shall not exceed 1% of the shares in issue[144]. - Any share options granted to a substantial shareholder or independent non-executive director in excess of 0.1% of the shares of the Company, with an aggregate value exceeding HK$5 million, require prior shareholder approval[145]. - The nominal consideration for accepting the option is HK$1.00, payable within 28 days from the date of offer[150]. - The Scheme is valid for a period of 10 years from its adoption date, ending on 25 September 2024[153]. - For all share options granted, 50% of the options are exercisable after 12 months and the remaining 50% after 24 months from the date of grant[154].

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 之 任 何 損 失 承 擔 任 何 責 任。 AFFLUENT PARTNERS HOLDINGS LIMITED 錢唐控股有限公司* （於開曼群島註冊成立之有限公司） （股份代號：1466） 網 址：http://www.affluent-partners.com 截 至2023年9月30日 止 六 個 月 之 中 期 業 績 公 告 錢 唐 控 股 有 限 公 司（「本 公 司」）董 事 會（「董 事 會」）謹 此 呈 報 本 公 司 及 其 附 屬 公 司（統 稱「本 集 團」）截 至2023年9月30日 止 六 個 月 之 簡 明 綜 合 中 期 業 績， 連 同2022年 同 期 之 比 較 數 字。 * 僅 供 識 別 – 1 – 簡 明 綜 合 中 期 ...

Financial Performance - Revenue for the year ended March 31, 2023, was HK$86,880,000, representing a 38.7% increase from HK$62,647,000 in 2022[16] - Gross profit decreased to HK$7,827,000, down 28.8% from HK$10,992,000 in the previous year[16] - Profit before income tax improved significantly to HK$8,726,000, compared to a loss of HK$15,462,000 in 2022, marking a change of 156.4%[16] - Basic earnings per share for 2023 was HK$0.01, a turnaround from a loss of HK$0.04 in 2022, reflecting a 125.0% increase[16] - The consolidated profit attributable to equity holders for FY23 was HK$8.7 million, a significant increase of 156.1% compared to a loss of HK$15.5 million in FY22[30] - Profit attributable to equity holders increased by HK$24.2 million or 156.1% to HK$8.7 million in FY23, compared to a loss of HK$15.5 million in FY22[74] Assets and Equity - Net assets increased to HK$78,338,000, a substantial rise of 118.4% from HK$35,867,000 in 2022[16] - Total equity as of 31 March 2023 was HK$78.3 million, representing an increase of 118.1% from HK$35.9 million in 2022[79] - Cash and cash equivalents rose to HK$41,261,000, up 75.0% from HK$23,585,000 in the previous year[16] - Cash and cash equivalents increased to HK$41.3 million as of 31 March 2023, up from HK$23.6 million in the previous year[80] Profitability Ratios - Gross profit margin decreased to 9.0% from 17.5%, a decline of 8.5 percentage points[17] - Return on equity improved to 18.7%, a significant increase of 61.8 percentage points from (43.1)% in 2022[17] - The return on capital for pearls and jewellery products was (2.0)% in FY23, down from 3.7% in FY22[32] - The return on capital employed in the sale of pearls and jewellery products was (2.0)% in 2023, compared to 3.7% in 2022[100] - The return on capital employed in strategic investment and financial services improved to 37.8% from (34.4)% in the previous year[100] Liquidity and Financial Position - Current ratio increased to 4.6 from 1.7, indicating improved liquidity[17] - The current ratio improved to 4.6 as of 31 March 2023, compared to 1.7 in the previous year, indicating better liquidity[80] - Gearing ratio decreased to 0.02 from 0.83, reflecting a stronger equity position[17] Business Strategy and Market Expansion - The Group plans to launch jade products in Q4 FY23 to boost sales and expand the customer base, targeting mainland China and Asian markets[33] - The Group is focusing investments in real estate, co-working spaces, and asset management sectors, with a potential acquisition of a new feminine products business[25] - The Group is preparing to enter the jade products market to broaden its customer base due to changing consumption patterns[63] - A memorandum of understanding was signed for a potential acquisition of a skincare solutions brand, which could enhance profitability[66] Operational Challenges and Adjustments - The Group has downsized its co-working space network in Hong Kong due to declining demand and has fully impaired investments in this sector in previous years[39] - The company has reduced the scale of its co-working space business due to significant impacts from social movements and the COVID-19 pandemic, leading to decreased demand and rental income[42] - The group has recognized its investment in the co-working space industry as a financial asset measured at fair value, which has been fully impaired[42] Risk Management - The Group faces strategic risk due to potential failure in identifying or implementing the correct strategy, which could adversely impact profitability and reputation[110] - Economic risk is present as downturns in economic conditions may lead to increased bad debts and lower asset values, affecting the Group's performance[110] - Credit risk involves potential financial loss if customers fail to meet their contractual obligations, necessitating thorough credit quality assessments before loan approvals[110] - Operational risk arises from increasing labor costs and shortages, which could significantly impact the Group's operations and profitability[111] - Liquidity risk indicates the possibility of not meeting financial obligations, prompting regular monitoring of liquidity and financial position[111] - Price risk is associated with changes in equity prices affecting the Group's income and asset values, requiring regular portfolio monitoring[111] - Exchange risk involves fluctuations in foreign exchange rates impacting the Group's income and asset values, necessitating close monitoring of financial statements[111] Corporate Governance - The company has complied with all code provisions of the Corporate Governance Code throughout the year ended 31 March 2023, with certain deviations disclosed[130] - The Board held 7 meetings during the year ended 31 March 2023, with attendance details provided in the report[140] - The Board believes the current composition satisfies the balance of expertise, skills, and experience required for effective corporate governance[135] - The Company has adopted the Model Code for Securities Transactions by Directors, with all Directors confirming compliance throughout the year[131] - The Board maintains a necessary balance of skills and experience to safeguard the interests of the Group and its shareholders[135] Diversity and Inclusion - The company has a female employee ratio of approximately 56% across all levels of the workforce, including senior management[161] - The Board has adopted a diversity policy emphasizing gender balance and aims to appoint at least one female director by December 31, 2024[160] - The Board Diversity Policy was amended in December 2018 to enhance diversity in terms of gender, age, and professional experience[155] - The company recognizes the importance of a diverse Board in achieving strategic objectives and sustainable development[156] Audit and Compliance - The Audit Committee held 2 meetings during the year ended March 31, 2023, to review interim and annual results, internal control review report, and risk assessment report[164] - The Company aims to appoint at least one female director by December 31, 2024, to enhance gender diversity on the Board[166] - The terms of reference for both the Audit and Remuneration Committees are available on the Company's and Stock Exchange's websites, ensuring transparency[170] - The Board is responsible for overseeing the preparation of financial statements for the year ended March 31, 2023, ensuring they present a true and fair view of the Group's state of affairs[194]

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 之 任 何 損 失 承 擔 任 何 責 任。 AFFLUENT PARTNERS HOLDINGS LIMITED 錢唐控股有限公司* （於開曼群島註冊成立之有限公司） （股份代號：1466） 截 至2023年3月31日 止 財 政 年 度 之 全 年 業 績 公 告 業 績 錢 唐 控 股 有 限 公 司（「本 公 司」）董 事 會（「董 事」或「董 事 會」）欣 然 宣 佈 本 公 司 及 其 附 屬 公 司（以 下 統 稱「本 集 團」）截 至2023年3月31日 止 年 度 之 綜 合 業 績， 連 同 去 年 之 比 較 數 字 如 下： * 僅 供 識 別 – 1 – 綜 合 收 益 表 截 至2023年3月31日 止 年 度 2023年 2022年 附 ...

Financial Performance - Revenue for the six months ended September 30, 2022, was HK$50,002,000, an increase from HK$31,159,000 in the same period of 2021, representing a growth of 60.6%[8]. - Gross profit for the same period was HK$12,763,000, significantly up from HK$122,000 in 2021[8]. - Operating profit for the period was HK$11,043,000, compared to an operating loss of HK$12,133,000 in the previous year[8]. - Profit before income tax was HK$10,258,000, a turnaround from a loss of HK$14,395,000 in the prior year[8]. - Profit attributable to equity holders of the Company for the period was HK$10,258,000, compared to a loss of HK$14,395,000 in 2021[8]. - Basic and diluted earnings per share for the period were 1.81 HK cents, compared to a loss of 5.39 HK cents in the previous year[8]. - Total comprehensive income for the period attributable to equity holders was HK$9,423,000, recovering from a loss of HK$14,395,000 in 2021[11]. - The total comprehensive income for the period was HK$10,258,000, a turnaround from a total comprehensive loss of HK$9,423,000 in the same period of 2021[21]. Assets and Liabilities - As of September 30, 2022, total assets amounted to HK$96,684,000, an increase from HK$79,555,000 as of March 31, 2022, representing a growth of approximately 21.5%[13]. - The net current assets increased to HK$76,479,000 from HK$34,092,000, indicating a significant improvement of approximately 124%[13]. - Total equity attributable to equity holders of the Company increased to HK$78,062,000 as of September 30, 2022, up from HK$35,867,000 as of March 31, 2022, reflecting a growth of approximately 117%[13]. - Total assets as of September 30, 2022, amounted to HK$98,450, with segment assets from Hong Kong at HK$74,282 and from the UK at HK$17,233[72]. - Total liabilities as of September 30, 2022, were HK$20,388, with segment liabilities from Hong Kong at HK$8,643 and from the PRC at HK$1,362[72]. - The Group's unallocated corporate assets were valued at HK$4,371, while unallocated corporate liabilities stood at HK$10,383[72]. Cash Flow - Cash used in operations for the six months ended September 30, 2022, was HK$10,712,000, which is a deterioration from HK$1,591,000 used in the same period of 2021[23]. - Cash and cash equivalents at the end of the period decreased to HK$17,289,000 in 2022 from HK$25,496,000 in 2021, a decline of approximately 32%[26]. - The company reported a net decrease in cash and cash equivalents of HK$5,889,000 for the six months ended September 30, 2022, compared to an increase of HK$1,072,000 in 2021[26]. - The effect of foreign exchange rate changes resulted in a decrease of HK$407,000 in cash and cash equivalents for the six months ended September 30, 2022[26]. Segment Information - For the six months ended September 30, 2022, segment revenue from the sale of pearls and jewellery products was HK$48,915, while strategic investment and financial services generated HK$50,002, totaling HK$98,917[53]. - Segment profit for the sale of pearls and jewellery products was HK$15,241, whereas strategic investment and financial services incurred a loss of HK$1,781, resulting in an overall segment profit of HK$13,460[54]. - Revenue from external customers for the six months ended 30 September 2022 was HK$50,002,000, a significant increase from HK$31,159,000 in the same period of 2021[112]. - Revenue from a single customer in the USA accounted for approximately HK$40,432,000, representing over 81% of total revenue for the group[113]. Credit and Receivables - The reversal of allowance for expected credit loss on trade receivables was HK$7,990,000, indicating improved collection performance[95]. - Trade receivables increased to HK$13,612,000 as of September 30, 2022, compared to HK$5,667,000 as of March 31, 2022, representing a significant growth[146]. - The allowance for expected credit losses (ECL) on trade receivables decreased from HK$17,639,000 to HK$9,637,000, indicating improved credit quality[147]. - The Group's net trade receivables as of September 30, 2022, were HK$13,612,000, reflecting a recovery from previous periods[147]. Investments - The Group holds a 33% equity interest in Dellos Group Limited and its subsidiaries as of September 30, 2022[133]. - The Group's investment in associates, particularly in Dellos F&B, has been fully written down due to its bankruptcy proceedings initiated in July 2020[138]. - The Group's management considers it highly unlikely that any future economic benefits will arise from the investment in Dellos Group[138]. Employee and Administrative Expenses - Administrative expenses increased to HK$7,390,000 from HK$6,861,000 in the previous year[8]. - Employee benefit expenses showed a significant increase, amounting to (HK$18,164,000) compared to HK$8,600,000 in the previous year[116]. Taxation - The company has not made any provision for Hong Kong profits tax due to tax losses carried forward, which are available for offset against estimated assessable profits[121]. - The PRC corporate income tax rate applicable to the company's subsidiaries in China remains at 25% for the estimated assessable profits during the period[122]. Other Financial Information - The company did not recommend any interim dividend for the six months ended 30 September 2022, consistent with the previous year where no dividend was declared[122]. - The Group's financial assets are classified as measured at amortised cost, reflecting the intention to collect contractual cash flows[192].

Financial Performance - Revenue for the year ended March 31, 2022, increased by 44.6% to HK$62,647,000 from HK$43,324,000 in 2021[12]. - Gross profit improved significantly to HK$10,992,000, compared to a gross loss of HK$8,623,000 in the previous year, marking a 227.5% change[12]. - Loss before income tax decreased by 70.3% to HK$15,462,000 from HK$52,077,000 in 2021[12]. - Basic and diluted loss per share improved to HK$0.04, a reduction of 81.0% from HK$0.21 in the prior year[12]. - The consolidated loss attributable to equity holders for FY22 was HK$15.5 million, a substantial decrease of 70% compared to HK$51.8 million in FY21[32]. - Revenue from the Pearls and Jewellery Business Segment increased from HK$41.2 million in FY21 to HK$59.9 million in FY22[34]. - The gross profit margin for FY22 was 17.5%, a significant improvement from (19.9)% in FY21, reflecting a change of 37.4 percentage points[14]. - Selling and Administrative expenses decreased by HK$5.7 million or 26.8% to HK$15.6 million in FY22, down from HK$21.3 million in FY21, due to cost control measures[49]. - Loss attributable to equity holders decreased by HK$36.3 million or 70.1% to HK$15.5 million in FY22, compared to HK$51.8 million in FY21[49]. Assets and Liabilities - Net assets decreased by 21.9% to HK$35,867,000 from HK$45,945,000 in 2021[12]. - Cash and cash equivalents also declined by 3.4% to HK$23,585,000 from HK$24,424,000[12]. - The current ratio decreased to 1.7 in FY22 from 2.0 in FY21[14]. - The gearing ratio increased to 0.83 in FY22 from 0.65 in FY21[14]. - Outstanding borrowings were HK$29.8 million as of March 31, 2022, compared to HK$30.0 million in 2021[50]. - As of March 31, 2022, total equity was HK$35.9 million, a decrease of 21.8% from HK$45.9 million in 2021[50]. Business Strategy and Future Outlook - The Group continues to explore new business opportunities to maximize shareholder value in the future[9]. - The Company maintains its investment in the co-working space industry as part of its strategic investment and financial services segment[9]. - The Group plans to focus investments in real estate, co-working spaces, and asset management sectors, particularly in Europe and Asia[26]. - The Group is optimistic about the demand for co-working spaces post-pandemic due to changes in working hours and locations[40]. - The Group plans to enhance its mature pearls and jewellery business while actively participating in global jewellery fairs to optimize operational efficiency[47]. Risk Management - The Group faces strategic, economic, credit, and business risks, with mitigating actions in place to address these challenges[74]. - Liquidity risk is present as the Group may not meet financial obligations as they fall due, necessitating regular monitoring of liquidity and financial position[77]. - Price risk arises from changes in equity prices affecting the Group's income and equity holdings, requiring regular portfolio monitoring and diversification[77]. - Exchange risk is linked to fluctuations in foreign exchange rates impacting income and asset values, necessitating close monitoring of financial statements and cash flow[77]. - The Group aims to mitigate people risk by providing competitive reward packages and ensuring a conducive working environment to retain key personnel[80]. Corporate Governance - The Company has complied with all provisions of the Corporate Governance Code throughout the year ended March 31, 2022, except for certain deviations disclosed[95]. - The Board is committed to achieving the highest standard of corporate governance consistent with stakeholder interests[100]. - The Group recognizes the importance of high standards of corporate governance to manage business risks and enhance transparency[100]. - The Board held 9 meetings during the year ended March 31, 2022, with attendance details provided in the report[109]. - The Company emphasizes Board diversity, considering factors such as gender, age, cultural background, and professional experience in its appointments[122]. Environmental and Social Responsibility - HBF Jewellery has complied with all relevant PRC environmental laws and regulations in all material respects during the year ended March 31, 2022[187]. - The Group emphasizes minimizing environmental impact and promoting sustainability for future generations[185]. - Further discussion on the Group's environmental issues and policies will be included in the Environmental, Social and Governance Report for the year ended March 31, 2022[187].